Diversified Healthcare Trust (DHC)
(Delayed Data from NSDQ)
$3.68 USD
+0.04 (1.10%)
Updated Oct 11, 2024 03:59 PM ET
After-Market: $3.68 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$3.68 USD
+0.04 (1.10%)
Updated Oct 11, 2024 03:59 PM ET
After-Market: $3.68 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Zacks News
SBA Communications (SBAC) Surpasses Q3 FFO and Revenue Estimates
by Zacks Equity Research
SBA Communications (SBAC) delivered FFO and revenue surprises of 1.97% and 3.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Piedmont Office (PDM) Q2 FFO Match Estimates
by Zacks Equity Research
Piedmont Office (PDM) delivered FFO and revenue surprises of 0% and 0.73%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Crown Castle (CCI) Q2 FFO and Revenues Surpass Estimates
by Zacks Equity Research
Crown Castle (CCI) delivered FFO and revenue surprises of 0.56% and 1.22%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Diversified Healthcare (DHC) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Diversified Healthcare (DHC) delivered FFO and revenue surprises of -350% and 2.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Diversified Healthcare (DHC) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Diversified Healthcare (DHC) delivered FFO and revenue surprises of -275% and 0.75%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Capstar Financial (CSTR) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Capstar Financial (CSTR) delivered earnings and revenue surprises of 9.80% and 1.79%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Diversified Healthcare (DHC) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Diversified Healthcare (DHC) delivered FFO and revenue surprises of -233.33% and -1.56%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Ventas (VTR) This Earnings Season?
by Zacks Equity Research
While Ventas (VTR) is well poised to bank on the senior housing industry's recovery that is likely to have aided it in Q2, disposition of assets and higher expenses might have been deterrents.
Diversified Healthcare (DHC) Tops Q2 FFO Estimates
by Zacks Equity Research
Diversified Healthcare (DHC) delivered FFO and revenue surprises of 150.00% and -6.44%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Is Diversified Healthcare (DHC) a Great Stock for Value Investors?
by Zacks Equity Research
Is Diversified Healthcare (DHC) a great pick from the value investor's perspective right now? Read on to know more.
Diversified Healthcare (DHC) Misses Q1 FFO and Revenue Estimates
by Zacks Equity Research
Diversified Healthcare (DHC) delivered FFO and revenue surprises of -33.33% and -0.27%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Ventas (VTR) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
While the gradual rebound in clinical activity is expected to have supported Ventas' (VTR) office segment performance, the pandemic-led concerns continued to be setbacks for its seniors housing business.
Is Recovery in the Cards for Welltower (WELL) in Q1 Earnings?
by Zacks Equity Research
Despite increased coverage of vaccine administration among senior housing residents, Welltower (WELL) witnesses a significant occupancy decline at its senior housing operating portfolio in Q1.
Life-Science Assets to Aid Ventas (VTR) Amid Pandemic Woes
by Zacks Equity Research
Amid the COVID-19 outbreak, which is taking a toll on Ventas' (VTR) senior housing operations, the company is attuning its portfolio with higher exposure to resilient office segment assets.
Welltower (WELL) Expects 1Q21 FFO to Reach Top-End of Outlook
by Zacks Equity Research
Backed by a rise in vaccination coverage, the removal of admission bans and a spike in move-ins, Welltower's (WELL) seniors housing occupancy decline moderated in March. This will aid Q1 results.
New Strong Sell Stocks for January 26th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Welltower's (WELL) Seniors Housing Occupancy Slip Continues in Q4
by Zacks Equity Research
While vaccinations renew hope for Welltower's (WELL) seniors housing portfolio, occupancy declines and seasonal move-outs continue to plague its performance.
Diversified Healthcare (DHC) Q3 FFO and Revenues Miss Estimates
by Zacks Equity Research
Diversified Healthcare (DHC) delivered FFO and revenue surprises of -50.00% and -0.31%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Top Ranked Value Stocks to Buy for October 26th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, October 26th.
Top Ranked Value Stocks to Buy for October 23rd
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, October 23rd.
Top Ranked Value Stocks to Buy for October 22nd
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, October 22nd
DHC vs. PEAK: Which Stock Is the Better Value Option?
by Zacks Equity Research
DHC vs. PEAK: Which Stock Is the Better Value Option?
Diversified Healthcare (DHC) Q2 FFO and Revenues Top Estimates
by Zacks Equity Research
Diversified Healthcare (DHC) delivered FFO and revenue surprises of 50.00% and 0.04%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Diversified Healthcare Trust (DHC) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Diversified Healthcare Trust (DHC) stock based on the movements in the options market lately.
Diversified Healthcare (DHC) Q1 FFO and Revenues Top Estimates
by Zacks Equity Research
Diversified Healthcare (DHC) delivered FFO and revenue surprises of 3.57% and 1.15%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?